英文名称 |
中文名称 |
CAS号 |
操作 |
Nepafenac |
奈帕酚胺 |
78281-72-8 |
详细
|
L 888607 Racemate |
1030017-51-6 |
1030017-51-6 |
详细
|
GKT136901 |
AK120765 |
955272-06-7 |
详细
|
VTX-27 |
1321924-70-2 |
1321924-70-2 |
详细
|
TNF-α-IN-1 |
TNF-Α-IN-1 |
444287-49-4 |
详细
|
YKL-05-099 |
化合物YKL-05-099 |
1936529-65-5 |
详细
|
S1p receptor agonist 1 |
CS-2465 |
1514888-56-2 |
详细
|
GSK-872 |
GSK872 |
1346546-69-7 |
详细
|
LY2955303 |
CS-2631 |
1433497-19-8 |
详细
|
Brensocatib |
AZD7986 |
1802148-05-5 |
详细
|
C-176 |
N-(4-碘苯基)-5-硝基呋喃-2-甲酰胺 |
314054-00-7 |
详细
|
Razuprotafib |
Razuprotafib |
1008510-37-9 |
详细
|
Olutasidenib |
OLUTASIDENIB |
1887014-12-1 |
详细
|
L-Valyl-L-phenylalanine |
H-VAL-PHE-OH |
3918-92-1 |
详细
|
Furprofen |
FURPROFEN |
66318-17-0 |
详细
|
Raleukin |
阿那白滞素 |
143090-92-0 |
详细
|
BCI hydrochloride |
(E/Z)-BCI HYDROCHLORIDE |
95130-23-7 |
详细
|
CA-170 |
化合物 T12378L |
1673534-76-3 |
详细
|
N6,N6-Dimethyladenosine |
N6,N6-二甲基腺苷 |
2620-62-4 |
详细
|
NS 398 |
抑制剂 |
123653-11-2 |
详细
|
Obafistat |
化合物OBAFISTAT |
2160582-57-8 |
详细
|
Lumiracoxib |
罗美昔布 |
220991-20-8 |
详细
|
(+/-)-Sulfinpyrazone |
磺吡酮 |
57-96-5 |
详细
|
Pexacerfont |
8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-A]-1,3,5-三嗪-4-胺 |
459856-18-9 |
详细
|
PF-4878691 |
532959-63-0 |
532959-63-0 |
详细
|
Etomoxir |
乙莫克舍 |
124083-20-1 |
详细
|
Ketorolac tromethamine salt |
酮咯酸氨丁三醇 |
74103-07-4 |
详细
|
SPL-707 |
SPL-707 |
2195361-33-0 |
详细
|
AS2717638 |
AS2717638 |
2148339-28-8 |
详细
|
N6-Etheno 2'-deoxyadenosine |
N6-亚乙烯基-2'-脱氧腺苷 |
68498-25-9 |
详细
|
NIK SMI1 |
NIK SMI1 |
1660114-31-7 |
详细
|
TMP778 |
化合物 T13172L |
1422053-04-0 |
详细
|
TRPV4 agonist-1 free base |
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- |
2314467-59-7 |
详细
|
Patamostat |
4-(2-succinimidoethylthio)phenyl 4-guanidinobenzoate |
114568-26-2 |
详细
|
Manitimus |
202057-76-9 |
202057-76-9 |
详细
|
BI-671800 |
2 - [ 4- [ 4 -(三氟甲基)苯甲酰胺基] ] ]苯甲基4,6 -二(二甲氨基) -嘧啶-5-乙酸 |
1093108-50-9 |
详细
|
RIPA-56 |
RIPA-56 |
1956370-21-0 |
详细
|
Sulindac |
舒林酸 |
38194-50-2 |
详细
|
Tazanolast |
他扎司特 |
82989-25-1 |
详细
|
Hexahydrocurcumin |
六氢姜黄素 |
36062-05-2 |
详细
|
Zaltoprofen |
扎托布洛芬 |
74711-43-6 |
详细
|
3'-Azido-3'-deoxy-5-fluorocytidine |
3'-AZIDO-3'-DEOXY-5-FLUOROCYTIDINE |
2095417-18-6 |
详细
|
RGX-104 |
RGX-104 |
610318-54-2 |
详细
|
BAY-218 |
CPD3504 |
2162982-11-6 |
详细
|
Ibufenac |
异丁芬酸 |
1553-60-2 |
详细
|
Ac-LEHD-AFC (trifluoroacetate salt) |
代他考昔 |
181695-72-7 |
详细
|
LDC7559 |
LDC7559 |
2407782-01-6 |
详细
|
Apyramide |
4-(acetylamino)phenyl 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate |
68483-33-0 |
详细
|
EMD527040 |
EMD527040 |
851333-14-7 |
详细
|
ATB-346 |
ATB 346 |
1226895-20-0 |
详细
|
Avelumab |
阿维鲁单抗 |
1537032-82-8 |
详细
|
CU-CPT-9a |
CU-CPT-9B, CPD2004 |
2165340-32-7 |
详细
|
PF-06747711 |
化合物 T16495 |
1892576-58-7 |
详细
|
Naltriben mesylate |
化合物 T23054 |
122517-78-6 |
详细
|
Linzagolix |
林扎戈利 |
935283-04-8 |
详细
|
PI3Kδ-IN-1 |
PI3Kδ-IN-1 |
1911564-39-0 |
详细
|
SPD304 dihydrochloride |
TNF-α inhibitor |
1049741-03-8 |
详细
|
SOCE inhibitor 1 |
SOCE inhibitor 1 |
2169316-15-6 |
详细
|
ML604440 |
ML 604440 |
1140517-08-3 |
详细
|
Roflupram |
1-Butanone, 1-[4-(difluoromethoxy)-3-[(tetrahydro-3-furanyl)oxy]phenyl]-3-methyl- |
1093412-18-0 |
详细
|
(S)-Coriolic acid |
13(S)-HYDROXYOCTADECA-9Z,11E-DIENOIC ACID |
29623-28-7 |
详细
|
Eliapixant |
依利哌嗪 |
1948229-21-7 |
详细
|
AZ2 |
AZ2 |
2231760-33-9 |
详细
|
CP 376395 |
CP 376395 |
175140-00-8 |
详细
|
PKA-IN-1 |
1-ACETAMIDO-4-CYANO-3-METHYLISOQUINOLINE |
179985-52-5 |
详细
|
SB-747651A dihydrochloride |
SB-747651A二盐酸盐 |
1781882-72-1 |
详细
|
Tolfenamic Acid |
托灭酸 |
13710-19-5 |
详细
|
SC 560 |
5-(4-氯苯基)-1-(4-甲氧基苯基)-3-(三氟甲基)-1H-吡唑 |
188817-13-2 |
详细
|
UCB9608 |
(S)-4-(6-氨基-1-甲基-1H-吡唑并[3,4-D]嘧啶-4-基)-N-(4-甲氧基-2-甲基苯基)-3-甲基哌嗪-1-甲酰胺 |
1616413-96-7 |
详细
|
N6-(2-Phenylethyl)adenosine |
N6-PHENETHYLADENOSINE; N6-PHENYLETHYLADENOSINE |
20125-39-7 |
详细
|
(αR,8aS)-GSK1614343 |
化合物 T27451 |
1092476-84-0 |
详细
|
J-2156 TFA |
化合物 J-2156 TFA |
2387505-73-7 |
详细
|
Zetomipzomib maleate |
ZETOMIPZOMIB MALEATE |
2170983-62-5 |
详细
|
A-770041 |
A-770041 |
869748-10-7 |
详细
|
Verucerfont |
3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-A]嘧啶-7-胺 |
885220-61-1 |
详细
|
NOD-IN-1 |
1-甲苯磺酰-1H-吲哚-2-甲酸乙酯 |
132819-92-2 |
详细
|
Icerguastat |
化合物SEPHIN 1 |
951441-04-6 |
详细
|
Zegocractin |
CS-2907 |
1713240-67-5 |
详细
|
H-151 |
H-151 |
941987-60-6 |
详细
|
SPR inhibitor 3 |
N-[2-(5-Hydroxy-2-methyl-1H-indol-3-yl)ethyl]-2-methoxyacetamide |
1292285-54-1 |
详细
|
MLT-748 |
MLT-748 |
1832578-30-9 |
详细
|
BMS-470539 dihydrochloride |
BMS 470539 DIHYDROCHLORIDE |
2341796-82-3 |
详细
|
Ly93 |
Ly93 |
1883528-69-5 |
详细
|
CRAC intermediate 2 |
4-(3,5-双(三氟甲基)-1H-吡唑-1-基)-苯胺 |
123066-64-8 |
详细
|
Ibuprofen Lysine |
布洛芬赖氨酸盐 |
57469-77-9 |
详细
|
Trimethylamine N-oxide-d9 |
N,N-Di(Methyl-d3)Methan-d3-aMine N-Oxide |
1161070-49-0 |
详细
|
(S)-Flurbiprofen |
(S)-氟比洛芬 |
51543-39-6 |
详细
|
Loxoprofen |
洛索洛芬 |
68767-14-6 |
详细
|
GSK3179106 |
GSK3179106 |
1627856-64-7 |
详细
|
TLR7 agonist 2 |
CS-2748 |
1642857-69-9 |
详细
|
Synta66 |
化合物SYNTA66 |
835904-51-3 |
详细
|
(S)-Ketoprofen |
右旋酮洛芬 |
22161-81-5 |
详细
|
PAP-1 |
4-(4-苯氧基丁氧基)-7H-呋喃并[3,2-G][1]苯并吡喃-7-酮 |
870653-45-5 |
详细
|
DuP 697 |
5-溴-2-(4-氟苯基)-3-(4-甲基磺酰基苯基)噻吩 |
88149-94-4 |
详细
|
TC-S 7005 |
TC-S 7005 |
1082739-92-1 |
详细
|
diABZI STING agonist-1 trihydrochloride |
DIABZI STING AGONIST-1 TRIHYDROCHLORIDE |
2138299-34-8 |
详细
|
Licofelone |
利克飞龙 |
156897-06-2 |
详细
|
Paquinimod |
帕奎莫德 |
248282-01-1 |
详细
|
Triflusal |
三氟醋柳酸 |
322-79-2 |
详细
|
Diflunisal |
二氟尼柳 |
22494-42-4 |
详细
|